低危妊娠滋养细胞肿瘤单药化疗耐药相关因素的分析与预测(4)
[8] 狄文，張梅莹.妊娠滋养细胞肿瘤耐药和复发的影响因素和处理[J].实用妇产科杂志，2019，35(6)：410-412.
[9] Chalouhi GE，Golfier F，Soignon P，et al.Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients： efficacy and toxicity[J].American Journal of Obstetrics& Gynecology，2009，200(6)：643 e1-e6.
[10] Hasanzadeh M，Tabari A，Homae F，et al.Evaluation of weekly intramuscular methotrexate in the treatment of low risk gestational trophoblastic neoplasia[J].Journal of Cancer Research and Therapeutics， 2014，10 (3) ：646-650.
[11] Winter MC，Tidy JA，Hills A，et al.Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia[J].Gynecologic Oncology ，2016，143(3)： 565–570.
[12] Mousavi AS，Zamani A，Khorasanizadeh F，et al.Resistance to single-agent chemotherapy and its risk factors in low-risk gestational trophoblastic neoplasms[J].J Obstet Gynaecol Res， 2015，41(5)：776-783.
[13] Anna E，Strohl，John R，et al. Postmolar choriocarcinoma： An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia[J].Gynecol Oncol，2016，141(2)：276-280.
(收稿日期：2020-07-11), http://www.100md.com(镇澜 郑祥钦 宋建榕 苏彦钊 陈玲思 陈宏)
[9] Chalouhi GE，Golfier F，Soignon P，et al.Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients： efficacy and toxicity[J].American Journal of Obstetrics& Gynecology，2009，200(6)：643 e1-e6.
[10] Hasanzadeh M，Tabari A，Homae F，et al.Evaluation of weekly intramuscular methotrexate in the treatment of low risk gestational trophoblastic neoplasia[J].Journal of Cancer Research and Therapeutics， 2014，10 (3) ：646-650.
[11] Winter MC，Tidy JA，Hills A，et al.Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia[J].Gynecologic Oncology ，2016，143(3)： 565–570.
[12] Mousavi AS，Zamani A，Khorasanizadeh F，et al.Resistance to single-agent chemotherapy and its risk factors in low-risk gestational trophoblastic neoplasms[J].J Obstet Gynaecol Res， 2015，41(5)：776-783.
[13] Anna E，Strohl，John R，et al. Postmolar choriocarcinoma： An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia[J].Gynecol Oncol，2016，141(2)：276-280.
(收稿日期：2020-07-11), http://www.100md.com(镇澜 郑祥钦 宋建榕 苏彦钊 陈玲思 陈宏)